The Effect of NADPH Oxidase and Creatine Supplementation on Microvascular Blood Flow Regulation - Trial NCT06018480
Access comprehensive clinical trial information for NCT06018480 through Pure Global AI's free database. This phase not specified trial is sponsored by Florida State University and is currently Recruiting. The study focuses on Endothelial Dysfunction. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Florida State University
Timeline & Enrollment
N/A
Aug 29, 2023
Apr 01, 2025
Primary Outcome
Concentrations of reactive oxygen species (ROS),Rate of skeletal muscle blood flow,Flow mediated dilation percentage
Summary
This research study seeks to determine the effects of an enzyme in the human body called
 NADPH oxidase (NOX) on blood flow. In addition, the study will investigate the benefits of
 creatine monohydrate, a common sports performance supplement, on blood food and vessel
 function. Participants will undergo two study arms, one in which they consume a high
 carbohydrate meal pre- and post-creatine monohydrate supplementation and one in which they
 will consume a high carbohydrate meal pre- and post-placebo supplementation. Blood flow and
 endothelial function will be assessed before and for 4 hours following the consumption of a
 high-carbohydrate meal pre and post-supplementation (creatine monohydrate and placebo).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06018480
Non-Device Trial